EPR Tumor Oximetry With CE India Ink

NCT03321903 · clinicaltrials.gov ↗

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped The research team is exploring device optimization

Conditions

Neoplasms, Malignant
Breast Neoplasm
Carcinoma, Basal Cell
Carcinoma, Squamous Cell
Melanoma
Skin Neoplasm
Head and Neck Neoplasms

Interventions

DEVICE: Carlo Erba Ink Injection
OTHER: EPR Oximetry Measurement

Sponsor

Philip Schaner

Collaborators

[object Object]